255 related articles for article (PubMed ID: 30612993)
1. Chemotherapeutic options for the treatment of human trichomoniasis.
Küng E; Fürnkranz U; Walochnik J
Int J Antimicrob Agents; 2019 Feb; 53(2):116-127. PubMed ID: 30612993
[TBL] [Abstract][Full Text] [Related]
2. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
Meites E; Gaydos CA; Hobbs MM; Kissinger P; Nyirjesy P; Schwebke JR; Secor WE; Sobel JD; Workowski KA
Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S837-48. PubMed ID: 26602621
[TBL] [Abstract][Full Text] [Related]
3. Should expedited partner treatment for women with Trichomonas vaginalis be recommended?
Kissinger P
Sex Transm Dis; 2010 Jun; 37(6):397-8. PubMed ID: 20453719
[No Abstract] [Full Text] [Related]
4. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.
Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL
Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167
[TBL] [Abstract][Full Text] [Related]
5. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
Cudmore SL; Delgaty KL; Hayward-McClelland SF; Petrin DP; Garber GE
Clin Microbiol Rev; 2004 Oct; 17(4):783-93, table of contents. PubMed ID: 15489348
[TBL] [Abstract][Full Text] [Related]
6. 20S Proteasome as a Drug Target in Trichomonas vaginalis.
O'Donoghue AJ; Bibo-Verdugo B; Miyamoto Y; Wang SC; Yang JZ; Zuill DE; Matsuka S; Jiang Z; Almaliti J; Caffrey CR; Gerwick WH; Eckmann L
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451503
[TBL] [Abstract][Full Text] [Related]
7. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
Seña AC; Bachmann LH; Hobbs MM
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
[TBL] [Abstract][Full Text] [Related]
8. In vitro effects of various plants extracts on the growth of Trichomonas vaginalis.
Sharafi SM; Yousefi M; Yousefi HA; Asghari G; Darani HY
Infect Disord Drug Targets; 2013 Oct; 13(5):322-7. PubMed ID: 24712672
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.
Dunne RL; Dunn LA; Upcroft P; O'Donoghue PJ; Upcroft JA
Cell Res; 2003 Aug; 13(4):239-49. PubMed ID: 12974614
[TBL] [Abstract][Full Text] [Related]
10. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
Forbes GL; Drayton R; Forbes GD
Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
[TBL] [Abstract][Full Text] [Related]
11. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.
Muzny CA; Blackburn RJ; Sinsky RJ; Austin EL; Schwebke JR
Clin Infect Dis; 2014 Sep; 59(6):834-41. PubMed ID: 24928292
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic aspects of trichomoniasis].
Vukićević J; Jankicević J
Srp Arh Celok Lek; 2003; 131(3-4):156-61. PubMed ID: 14608880
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effect of some medicinal plants on cultured Trichomonas Vaginalis.
Selim MA; Fawzy EM; Abd El-Rahman EM; Abdel Hady RS; Badr MS; Abdel Hamed EF
J Infect Dev Ctries; 2020 Jul; 14(7):793-799. PubMed ID: 32794472
[TBL] [Abstract][Full Text] [Related]
14. Drug repositioning for novel antitrichomonas from known antiprotozoan drugs using hierarchical screening.
Meneses-Marcel A; Marrero-Ponce Y; Ibáñez-Escribano A; Gómez-Barrio A; Escario JA; Barigye SJ; Terán E; García-Jacas CR; Machado-Tugores Y; Nogal-Ruiz JJ; Arán-Redó VJ
Future Med Chem; 2018 Apr; 10(8):863-878. PubMed ID: 29589477
[TBL] [Abstract][Full Text] [Related]
15. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis.
Wendel KA; Erbelding EJ; Gaydos CA; Rompalo AM
Clin Infect Dis; 2002 Sep; 35(5):576-80. PubMed ID: 12173132
[TBL] [Abstract][Full Text] [Related]
16. Trichomonas vaginalis Treated With Boric Acid in a Metronidazole Allergic Female.
Backus KV; Muzny CA; Beauchamps LS
Sex Transm Dis; 2017 Feb; 44(2):120. PubMed ID: 27984554
[No Abstract] [Full Text] [Related]
17. Trichomoniasis: the "neglected" sexually transmitted disease.
Meites E
Infect Dis Clin North Am; 2013 Dec; 27(4):755-64. PubMed ID: 24275268
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Punica granatum extract on in-vitro and in-vivo control of Trichomonas vaginalis.
El-Sherbini GM; Ibrahim KM; El Sherbiny ET; Abdel-Hady NM; Morsy TA
J Egypt Soc Parasitol; 2010 Apr; 40(1):229-44. PubMed ID: 20503601
[TBL] [Abstract][Full Text] [Related]
19. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
van Schalkwyk J; Yudin MH;
J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
Kissinger PJ; Gaydos CA; Seña AC; Scott McClelland R; Soper D; Secor WE; Legendre D; Workowski KA; Muzny CA
Clin Infect Dis; 2022 Apr; 74(Suppl_2):S152-S161. PubMed ID: 35416973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
